Cardiac protection takes off

Cardiovascular Research

Volumn 83, Issue 2, 2009, Pages 162-164

  Piper, Hans Michael ^a   Garcia Dorado, David ^b  

^a JUSTUS LIEBIG UNIVERSITY   (Germany)

^b HOSPITAL UNIVERSITARI VALL D HEBRON   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLIC GMP; NITRIC OXIDE; PHOSPHODIESTERASE V INHIBITOR; CARDIOVASCULAR AGENT;

EDITORIAL; HEART MUSCLE ISCHEMIA; HEART PROTECTION; HUMAN; IN VITRO STUDY; IN VIVO CULTURE; MITOCHONDRIAL PERMEABILITY; MITOCHONDRION; NONHUMAN; OUTCOME ASSESSMENT; PATHOPHYSIOLOGY; PRIORITY JOURNAL; REPERFUSION INJURY; ANIMAL; CELL PROTECTION; HEART INFARCTION; HEART INFARCTION PREVENTION; HEART MUSCLE; HEART MUSCLE REVASCULARIZATION; METHODOLOGY; PATHOLOGY; TRANSLUMINAL CORONARY ANGIOPLASTY; TREATMENT OUTCOME;

ANGIOPLASTY, TRANSLUMINAL, PERCUTANEOUS CORONARY; ANIMALS; CARDIOVASCULAR AGENTS; CYTOPROTECTION; HUMANS; ISCHEMIC PRECONDITIONING, MYOCARDIAL; MYOCARDIAL INFARCTION; MYOCARDIAL REVASCULARIZATION; MYOCARDIUM; REPERFUSION INJURY; TREATMENT OUTCOME;

EID: 67650236398     PISSN: 00086363     EISSN: 17553245     Source Type: Journal    
DOI: 10.1093/cvr/cvp186     Document Type: Editorial

References (10)

1. Inserte J, Barrabés JA, Hernando V, Garcia-Dorado D. Orphan targets for reperfusion injury. Cardiovasc Res 2009;83:169-178.
2. Hausenloy DJ, Yellon DM. Cardioprotective growth factors. Cardiovasc Res 2009;83:179-194.
3. Calvert JW, Lefer DJ. Myocardial protection by nitrite. Cardiovasc Res 2009;83:195-203.
4. Reffelmann T, Kloner RA. Phosphodiesterase-5 inhibitors: are they cardioprotective? Cardiovasc Res 2009;83:204-212.
5. Zorov DB, Juhaszova M, Yaniv Y, Bradley Nuss H, Wang S, Sollott SJ. Regulation and pharmacology of the mitochondrial permeability transition pore. Cardiovasc Res 2009;83:213-225.
6. Gomez L, Bo L, Mewton N, Sanchez I, Piot C, Elbaz M et al. Inhibition of mitochondrial permeability transition pore opening: translation to patients. Cardiovasc Res 2009;83:226-233.
7. Granfeldt A, Lefer DJ, Vinten-Johansen J. Protective ischaemia in patients: preconditioning and postconditioning. Cardiovasc Res 2009;83:234-246.
8. Boengler K, Schulz R, Heusch G. Loss of cardioprotection with ageing. Cardiovasc Res 2009;83:247-261.
9. Beyersdorf F. The use of controlled reperfusion strategies in cardiac surgery to minimize ischaemia/reperfusion damage. Cardiovasc Res 2009;83:262-268.
10. Takemura G, Nakagawa M, Kanamori H, Minatoguchi S, Fujiwara H. Benefits of reperfusion beyond infarct size limitation. Cardiovasc Res 2009;83:269-276.